| Not Yet Recruiting | CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) NCT07153289 | University Hospital Tuebingen | Phase 1 / Phase 2 |
| Recruiting | Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT07259317 | Corcept Therapeutics | Phase 2 |
| Active Not Recruiting | A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies NCT06974734 | Pfizer | Phase 1 |
| Active Not Recruiting | A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in NCT06704724 | Pfizer | Phase 1 |
| Not Yet Recruiting | A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS NCT05621824 | Peking Union Medical College Hospital | — |
| Not Yet Recruiting | Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC NCT06573398 | Ruijin Hospital | Phase 2 |
| Recruiting | A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in NCT06447662 | Pfizer | Phase 1 |
| Recruiting | Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatu NCT05475366 | Institut Curie | N/A |
| Unknown | Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma NCT05489458 | BUSQUETS, JULI | — |
| Completed | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) NCT05461430 | Travera Inc | — |
| Unknown | The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer NCT03403101 | Fudan University | Phase 2 |
| Completed | Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma NCT04146441 | St. Olavs Hospital | Phase 2 |
| Completed | Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) NCT03513705 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Unknown | Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer NCT03432624 | Fudan University | — |
| Unknown | Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. NCT03500068 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Completed | A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adeno NCT02993731 | Sumitomo Pharma America, Inc. | Phase 3 |
| Unknown | Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of t NCT02817308 | Rambam Health Care Campus | N/A |
| Completed | Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors NCT02658214 | AstraZeneca | Phase 1 |
| Unknown | Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarci NCT02928081 | West China Hospital | N/A |
| Completed | Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selectio NCT02750657 | University Health Network, Toronto | — |
| Completed | Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer NCT02653313 | Oryx GmbH & Co. KG | Phase 1 / Phase 2 |
| Unknown | According CTC to Compare the Influences of Different Methods to Remove the PDAC NCT02451384 | Shanghai Zhongshan Hospital | N/A |
| Unknown | Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer NCT02529579 | Changhai Hospital | Phase 1 / Phase 2 |
| Terminated | Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients NCT02456051 | University of Roma La Sapienza | — |
| Completed | Continuous Monitoring on the General Ward NCT02933307 | Radboud University Medical Center | N/A |
| Completed | Circulating Tumor Cells in Operative Blood NCT02150746 | University of Florida | — |
| Completed | An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy NCT02310230 | Donald Mathews | N/A |
| Completed | Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) NCT01808638 | Silence Therapeutics GmbH | Phase 1 / Phase 2 |
| Completed | A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 NCT01608711 | Agensys, Inc. | Phase 2 |
| Completed | A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Re NCT01478685 | Celgene | Phase 1 |
| Unknown | Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer NCT01394120 | Sofia Perea, Director Clinical Trials Unit. | Phase 2 |
| Terminated | Amatuximab for High Mesothelin Cancers NCT01413451 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. NCT05723978 | Tianjin Medical University Cancer Institute and Hospital | — |
| Completed | A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer NCT00902291 | Astellas Pharma Inc | Phase 2 |
| Completed | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. NCT00471146 | Pfizer | Phase 3 |
| Withdrawn | Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer NCT00226746 | New York Presbyterian Brooklyn Methodist Hospital | Phase 2 |